Nuvation Bio Financial Overview
Nuvation Bio's market cap is currently $2.93B. The company's EPS TTM is $-0.16; its P/E ratio is -14.04; Nuvation Bio is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
